Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

CytoBinning: Immunological insights from multi-dimensional data.

Shen Y, Chaigne-Delalande B, Lee RWJ, Losert W.

PLoS One. 2018 Oct 31;13(10):e0205291. doi: 10.1371/journal.pone.0205291. eCollection 2018.

2.

STAT5B: A Differential Regulator of the Life and Death of CD4+ Effector Memory T Cells.

Majri SS, Fritz JM, Villarino AV, Zheng L, Kanellopoulou C, Chaigne-Delalande B, Grönholm J, Niemela JE, Afzali B, Biancalana M, Pittaluga S, Sun A, Cohen JL, Holland SM, O'Shea JJ, Uzel G, Lenardo MJ.

J Immunol. 2018 Jan 1;200(1):110-118. doi: 10.4049/jimmunol.1701133. Epub 2017 Nov 29.

3.

B Cell Anomalies in Autoimmune Retinopathy (AIR).

Stansky E, Biancotto A, Dagur PK, Gangaputra S, Chaigne-Delalande B, Nussenblatt RB, Sen HN, McCoy JP Jr.

Invest Ophthalmol Vis Sci. 2017 Jul 1;58(9):3600-3607. doi: 10.1167/iovs.17-21704.

4.

Modulation of Immune Responses by Extracellular Vesicles From Retinal Pigment Epithelium.

Knickelbein JE, Liu B, Arakelyan A, Zicari S, Hannes S, Chen P, Li Z, Grivel JC, Chaigne-Delalande B, Sen HN, Margolis L, Nussenblatt RB.

Invest Ophthalmol Vis Sci. 2016 Aug 1;57(10):4101-7. doi: 10.1167/iovs.15-18353.

5.

Elevated CD1c+ Myeloid Dendritic Cell Proportions Associate With Clinical Activity and Predict Disease Reactivation in Noninfectious Uveitis.

Chen P, Urzua CA, Knickelbein JE, Kim JS, Li Z, Hannes S, Kuo D, Chaigne-Delalande B, Armbrust K, Tucker W, Liu B, Agrón E, Sen HN, Nussenblatt RB.

Invest Ophthalmol Vis Sci. 2016 Apr;57(4):1765-72. doi: 10.1167/iovs.15-18357.

6.

Identification of a novel mutation in MAGT1 and progressive multifocal leucoencephalopathy in a 58-year-old man with XMEN disease.

Dhalla F, Murray S, Sadler R, Chaigne-Delalande B, Sadaoka T, Soilleux E, Uzel G, Miller J, Collins GP, Hatton CS, Bhole M, Ferry B, Chapel HM, Cohen JI, Patel SY.

J Clin Immunol. 2015 Feb;35(2):112-8. doi: 10.1007/s10875-014-0116-2. Epub 2014 Dec 13. Review.

7.

X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection, and neoplasia disease: a combined immune deficiency with magnesium defect.

Ravell J, Chaigne-Delalande B, Lenardo M.

Curr Opin Pediatr. 2014 Dec;26(6):713-9. doi: 10.1097/MOP.0000000000000156. Review.

8.

Clinical utility gene card for: X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection, and neoplasia (XMEN).

Li FY, Chaigne-Delalande B, Rao VK, Zhang Y, Matthews H, Kuijpers TT, Su H, Uzel G, Lenardo MJ.

Eur J Hum Genet. 2015 Jun;23(6). doi: 10.1038/ejhg.2014.179. Epub 2014 Sep 10. No abstract available.

9.

Divalent cation signaling in immune cells.

Chaigne-Delalande B, Lenardo MJ.

Trends Immunol. 2014 Jul;35(7):332-44. doi: 10.1016/j.it.2014.05.001. Epub 2014 Jun 2. Review.

10.

XMEN disease: a new primary immunodeficiency affecting Mg2+ regulation of immunity against Epstein-Barr virus.

Li FY, Chaigne-Delalande B, Su H, Uzel G, Matthews H, Lenardo MJ.

Blood. 2014 Apr 3;123(14):2148-52. doi: 10.1182/blood-2013-11-538686. Epub 2014 Feb 18. Review.

11.

Mg2+ regulates cytotoxic functions of NK and CD8 T cells in chronic EBV infection through NKG2D.

Chaigne-Delalande B, Li FY, O'Connor GM, Lukacs MJ, Jiang P, Zheng L, Shatzer A, Biancalana M, Pittaluga S, Matthews HF, Jancel TJ, Bleesing JJ, Marsh RA, Kuijpers TW, Nichols KE, Lucas CL, Nagpal S, Mehmet H, Su HC, Cohen JI, Uzel G, Lenardo MJ.

Science. 2013 Jul 12;341(6142):186-91. doi: 10.1126/science.1240094.

12.

Congenital B cell lymphocytosis explained by novel germline CARD11 mutations.

Snow AL, Xiao W, Stinson JR, Lu W, Chaigne-Delalande B, Zheng L, Pittaluga S, Matthews HF, Schmitz R, Jhavar S, Kuchen S, Kardava L, Wang W, Lamborn IT, Jing H, Raffeld M, Moir S, Fleisher TA, Staudt LM, Su HC, Lenardo MJ.

J Exp Med. 2012 Nov 19;209(12):2247-61. doi: 10.1084/jem.20120831. Epub 2012 Nov 5.

13.

CD95 triggers Orai1-mediated localized Ca2+ entry, regulates recruitment of protein kinase C (PKC) β2, and prevents death-inducing signaling complex formation.

Khadra N, Bresson-Bepoldin L, Penna A, Chaigne-Delalande B, Ségui B, Levade T, Vacher AM, Reiffers J, Ducret T, Moreau JF, Cahalan MD, Vacher P, Legembre P.

Proc Natl Acad Sci U S A. 2011 Nov 22;108(47):19072-7. doi: 10.1073/pnas.1116946108. Epub 2011 Nov 7.

14.

Loss of MAGT1 abrogates the Mg2+ flux required for T cell signaling and leads to a novel human primary immunodeficiency.

Li FY, Lenardo MJ, Chaigne-Delalande B.

Magnes Res. 2011 Sep;24(3):S109-14. doi: 10.1684/mrh.2011.0286. Review.

15.

Exposed hydrophobic residues in human immunodeficiency virus type 1 Vpr helix-1 are important for cell cycle arrest and cell death.

Barnitz RA, Chaigne-Delalande B, Bolton DL, Lenardo MJ.

PLoS One. 2011;6(9):e24924. doi: 10.1371/journal.pone.0024924. Epub 2011 Sep 16.

16.

Second messenger role for Mg2+ revealed by human T-cell immunodeficiency.

Li FY, Chaigne-Delalande B, Kanellopoulou C, Davis JC, Matthews HF, Douek DC, Cohen JI, Uzel G, Su HC, Lenardo MJ.

Nature. 2011 Jul 27;475(7357):471-6. doi: 10.1038/nature10246.

17.

The naturally processed CD95L elicits a c-yes/calcium/PI3K-driven cell migration pathway.

Tauzin S, Chaigne-Delalande B, Selva E, Khadra N, Daburon S, Contin-Bordes C, Blanco P, Le Seyec J, Ducret T, Counillon L, Moreau JF, Hofman P, Vacher P, Legembre P.

PLoS Biol. 2011 Jun;9(6):e1001090. doi: 10.1371/journal.pbio.1001090. Epub 2011 Jun 21.

18.

Human immunodeficiency virus type 1 Vif causes dysfunction of Cdk1 and CyclinB1: implications for cell cycle arrest.

Sakai K, Barnitz RA, Chaigne-Delalande B, Bidère N, Lenardo MJ.

Virol J. 2011 May 11;8:219. doi: 10.1186/1743-422X-8-219.

19.

Actin-independent exclusion of CD95 by PI3K/AKT signalling: implications for apoptosis.

Pizon M, Rampanarivo H, Tauzin S, Chaigne-Delalande B, Daburon S, Castroviejo M, Moreau P, Moreau JF, Legembre P.

Eur J Immunol. 2011 Aug;41(8):2368-78. doi: 10.1002/eji.201041078. Epub 2011 Jul 4.

20.

TGFbeta-induced endothelial podosomes mediate basement membrane collagen degradation in arterial vessels.

Rottiers P, Saltel F, Daubon T, Chaigne-Delalande B, Tridon V, Billottet C, Reuzeau E, Génot E.

J Cell Sci. 2009 Dec 1;122(Pt 23):4311-8. doi: 10.1242/jcs.057448. Epub 2009 Nov 3.

21.

CD95 engagement mediates actin-independent and -dependent apoptotic signals.

Chaigne-Delalande B, Mahfouf W, Daburon S, Moreau JF, Legembre P.

Cell Death Differ. 2009 Dec;16(12):1654-64. doi: 10.1038/cdd.2009.111. Epub 2009 Aug 14.

22.

The necrotic signal induced by mycophenolic acid overcomes apoptosis-resistance in tumor cells.

Guidicelli G, Chaigne-Delalande B, Dilhuydy MS, Pinson B, Mahfouf W, Pasquet JM, Mahon FX, Pourquier P, Moreau JF, Legembre P.

PLoS One. 2009;4(5):e5493. doi: 10.1371/journal.pone.0005493. Epub 2009 May 11.

23.

An atypical necrotic signal induced by immunosuppressive and anti-viral agents.

Chaigne-Delalande B, Guidicelli G, Couzi L, Legembre P.

Autophagy. 2009 Apr;5(3):425-7. Epub 2009 Apr 28.

PMID:
19221465
24.

The immunosuppressor mycophenolic acid kills activated lymphocytes by inducing a nonclassical actin-dependent necrotic signal.

Chaigne-Delalande B, Guidicelli G, Couzi L, Merville P, Mahfouf W, Bouchet S, Molimard M, Pinson B, Moreau JF, Legembre P.

J Immunol. 2008 Dec 1;181(11):7630-8.

25.

Localization of Fas/CD95 into the lipid rafts on down-modulation of the phosphatidylinositol 3-kinase signaling pathway.

Bénéteau M, Pizon M, Chaigne-Delalande B, Daburon S, Moreau P, De Giorgi F, Ichas F, Rebillard A, Dimanche-Boitrel MT, Taupin JL, Moreau JF, Legembre P.

Mol Cancer Res. 2008 Apr;6(4):604-13. doi: 10.1158/1541-7786.MCR-07-0331.

26.

Rewinding the DISC.

Chaigne-Delalande B, Moreau JF, Legembre P.

Arch Immunol Ther Exp (Warsz). 2008 Jan-Feb;56(1):9-14. doi: 10.1007/s00005-008-0002-9. Epub 2008 Feb 5. Review.

PMID:
18250974
27.

Nonadherent cells switch to a Rac-mediated, SHIP regulated, Akt activation mode for survival.

Chaigne-Delalande B, Anies G, Kramer I, Genot E.

Oncogene. 2008 Mar 20;27(13):1876-85. Epub 2007 Oct 1.

PMID:
17906692
28.

RhoGTPases and p53 are involved in the morphological appearance and interferon-alpha response of hairy cells.

Chaigne-Delalande B, Deuve L, Reuzeau E, Basoni C, Lafarge D, Varon C, Tatin F, Anies G, Garand R, Kramer I, Génot E.

Am J Pathol. 2006 Feb;168(2):562-73.

29.

Soluble mannose 6-phosphate/insulin-like growth factor II (IGF-II) receptor inhibits interleukin-6-type cytokine-dependent proliferation by neutralization of IGF-II.

Duplomb L, Chaigne-Delalande B, Vusio P, Raher S, Jacques Y, Godard A, Blanchard F.

Endocrinology. 2003 Dec;144(12):5381-9. Epub 2003 Aug 28.

PMID:
12959977

Supplemental Content

Loading ...
Support Center